Reference Source

AZZEFERAN-AZSAFFRON MMC · 66-41 · AZERBAIJAN

For AZZEFERAN-AZSAFFRON MMC · 66-41 · AZERBAIJAN, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is AZERBAIJAN; product is Saffron | Saffron; product code is 28 A - - 40 Saffron, Whole (Spice) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 04/14/2026; address is Ilgar Mirzayev Str. 11d , Baku, Baki AZERBAIJAN, verified against its source on 2026-09-16.

Firm
AZZEFERAN-AZSAFFRON MMC verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
AZERBAIJAN verified
Address
Ilgar Mirzayev Str. 11d , Baku, Baki AZERBAIJAN verified
Date published
04/14/2026 verified
Product code
28 A - - 40 Saffron, Whole (Spice) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
Product
Saffron | Saffron each item verified
FDA notes
This product appears to be an unapproved new drug as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p) as the product labeling and website includes statements such as (not an all-inclusive list): “…Saffron is used in the treatment of various diseases such as functional disorders of the heart, cancer, inflammation of the kidneys and liver, seizures, gastrointestinal diseases. Since ancient times saffron has been used as a strong bacteri-cidal . . . Saffron also has a positive effect against the herpes virus.” | This product appears to be an unapproved new drug as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p) as the product labeling and website includes statements such as (not an all-inclusive list): “…Saffron is used in the treatment of various diseases such as functional disorders of the heart, cancer, inflammation of the kidneys and liver, seizures, gastrointestinal diseases. Since ancient times saffron has been used as a strong bacteri-cidal . . . Saffron also has a positive effect against the herpes virus.” each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

AZZEFERAN-AZSAFFRON MMC Date Published : 04/14/2026 Ilgar Mirzayev Str. 11d , Baku, Baki AZERBAIJAN 28 A - - 40 Saffron, Whole (Spice) Date Published: 04/14/2026 Desc: Saffron Notes: This product appears to be an unapproved new drug as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p) as the product labeling and website includes statements such as (not an all-inclusive list): “…Saffron is used in the treatment of various diseases such as functional disorders of the heart, cancer, inflammation of the kidneys and liver, seizures, gastrointestinal diseases. Since ancient times saffron has been used as a strong bacteri-cidal . . . Saffron also has a positive effect against the herpes virus.” 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 04/14/2026 Desc: Saffron Notes: This product appears to be an unapproved new drug as defined by section 201(p) of the FD&C Act, 21 U.S.C. 321(p) as the product labeling and website includes statements such as (not an all-inclusive list): “…Saffron is used in the treatment of various diseases such as functional disorders of the heart, cancer, inflammation of the kidneys and liver, seizures, gastrointestinal diseases. Since ancient times saffron has been used as a strong bacteri-cidal . . . Saffron also has a positive effect against the herpes virus.”

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.